SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037060
Filing Date
2022-11-08
Accepted
2022-11-08 16:47:48
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20220930.htm   iXBRL 10-Q 3099141
2 EX-31.1 abcl-ex311_69.htm EX-31.1 20975
3 EX-31.2 abcl-ex312_68.htm EX-31.2 20941
4 EX-32.1 abcl-ex321_66.htm EX-32.1 9698
5 EX-32.2 abcl-ex322_67.htm EX-32.2 9675
6 GRAPHIC gjuqujyvv1i0000001.jpg GRAPHIC 66764
  Complete submission text file 0001564590-22-037060.txt   8091637

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20220930.xsd EX-101.SCH 44033
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20220930_cal.xml EX-101.CAL 51715
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20220930_def.xml EX-101.DEF 154894
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20220930_lab.xml EX-101.LAB 358808
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20220930_pre.xml EX-101.PRE 273204
59 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20220930_htm.xml XML 1146071
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 221369610
SIC: 2834 Pharmaceutical Preparations